Interaction databaseSupplement × PrescriptionReviewed May 2026

Amlodipine and Berberine, a caution.

Berberine is a clinically demonstrated inhibitor of CYP3A4, the main enzyme that clears amlodipine. Co-administration can raise amlodipine plasma levels and prolong its half-life, increasing the risk of excessive blood pressure lowering, peripheral edema, dizziness, and reflex tachycardia. The effect builds over days because berberine accumulates with repeated dosing.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Amlodipine and Berberine
Pair type
Caution
Evidence (highest tier)
Moderate
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Moderate evidence

Caution

What is happening. Berberine is a clinically demonstrated inhibitor of CYP3A4, the main enzyme that clears amlodipine. Co-administration can raise amlodipine plasma levels and prolong its half-life, increasing the risk of excessive blood pressure lowering, peripheral edema, dizziness, and reflex tachycardia. The effect builds over days because berberine accumulates with repeated dosing.

Mechanism. Repeated berberine dosing in humans reduces CYP3A4 (and CYP2D6, CYP2C9) activity, slowing oxidative metabolism of amlodipine. Rat data also show inhibition of intestinal P-gp, which can further raise oral bioavailability.

Recommendation. Avoid pairing berberine with amlodipine unless your prescriber agrees, and if you do, separate doses by at least 4 hours and monitor your blood pressure for 1-2 weeks. Reduce or stop berberine if your readings fall below your usual range, or you develop new lightheadedness or swelling.

Minimum separation. 240

Sources (2)
  1. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7. PMID 21870106
  2. Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol. 2002;91(4):193-7. PMID 12530470

Stack Score

How this pair moves the number.

Effect on the composite score

If both Amlodipine and Berberine are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.